India Strengthens Gene Therapy Framework Amid Clinical Progress

India’s push to lead in gene therapy clinical progress took center stage in Parliament today as officials from the government detailed how the country is advancing cutting?edge treatments while relying on a firm regulatory system.  

The update highlighted India’s ongoing efforts to expand gene therapy research and early clinical progress in treating genetic disorders, backed by structured policy guidance that aims to keep innovation safe and ethical.

The government stressed that India already has a strong regulatory ecosystem in place for advanced medical interventions like gene therapy and gene editing, including CRISPR?based techniques, gene augmentation, and cell?based treatments. This framework is meant to balance patient safety with scientific advancement and help transform how conditions rooted in genetic causes are treated rather than simply managed over a lifetime.

Also Read: Role of Wellness in Corporate & Community Health

A standout example of India’s progress in this space is early clinical research in gene therapy for Hemophilia A, where trials conducted within the country have shown sustained production of Factor?VIII. This indicates a potential reduction in bleeding episodes and a decreased need for lifelong treatment, marking a significant step in India’s early clinical progress for genetic disease therapies.

Officials reaffirmed that the National Guidelines for Gene Therapy, created in 2019 by the Indian Council of Medical Research and the Department of Biotechnology with oversight from the Central Drugs Standard Control Organisation, are guiding these efforts. These rules are designed to ensure ethical conduct and scientific integrity as India scales up its clinical research in advanced therapies.

Beyond gene therapy for Hemophilia A, the government’s update signaled a broader focus on advanced biologics and emerging treatments that could reshape medical care in the future. As India’s regulatory pathways evolve alongside its clinical research capacity, there’s a growing expectation that gene therapy could play a key role in treating a range of diseases with precision medicine approaches.